Report overview
Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2).
This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy for Diabetes and Related Conditions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy for Diabetes and Related Conditions. This report contains market size and forecasts of Stem Cell Therapy for Diabetes and Related Conditions in global, including the following market information:
Global Stem Cell Therapy for Diabetes and Related Conditions Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Stem Cell Therapy for Diabetes and Related Conditions market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
NSI-566 is the stem cell therapy candidate under development by one of the key companies Neuralstem. The molecule is being developed for the treatment of individuals with diabetic neuropathy and is currently in the pre-clinical development stage. The mechanism of action of this stem cell therapy includes cell replacement that eventually leads to neurogenesis stimulation.
We surveyed the Stem Cell Therapy for Diabetes and Related Conditions companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Stem Cell Therapy for Diabetes and Related Conditions Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Stem Cell Therapy for Diabetes and Related Conditions Market Segment Percentages, by Type, 2022 (%)
Monotherapy
Combination Therapy
Global Stem Cell Therapy for Diabetes and Related Conditions Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Stem Cell Therapy for Diabetes and Related Conditions Market Segment Percentages, by Application, 2022 (%)
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Diabetic Foot Ulcer
Diabetic Nephropathy
Diabetic Neuropathy
Global Stem Cell Therapy for Diabetes and Related Conditions Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Stem Cell Therapy for Diabetes and Related Conditions Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Stem Cell Therapy for Diabetes and Related Conditions revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Stem Cell Therapy for Diabetes and Related Conditions revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Athersys
Mesoblast
Caladrius Biosciences
Sanofi
Novo Nordisk
Outline of Major Chapters:
Chapter 1: Introduces the definition of Stem Cell Therapy for Diabetes and Related Conditions, market overview.
Chapter 2: Global Stem Cell Therapy for Diabetes and Related Conditions market size in revenue.
Chapter 3: Detailed analysis of Stem Cell Therapy for Diabetes and Related Conditions company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Stem Cell Therapy for Diabetes and Related Conditions in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
